Antibodies and Immunology News and Research

Latest Antibodies and Immunology News and Research

Nanodisc Platform Shows How Antibodies Really Target Viruses

Viruses are masters at entering human cells, thanks to specialized proteins that coat their surfaces.

13 Apr 2026

UTMB Researchers Develop AI Pipeline to Accelerate Pan-Alphavirus Vaccine Development

A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, PhD, and Peter McCaffrey, MD, has developed a new computational pipeline that could dramatically accelerate the development of vaccines against a group of mosquito-borne viruses known as alphavirus.

11 Apr 2026

Natural Skincare Hero Madecassic Acid Found to Combat Antibiotic Resistance

Fans of Korean skincare may be familiar with 'hero ingredient' Madecassic acid for its skin-soothing properties, but researchers at the University of Kent have revealed its greater potential for use in the battle against antibiotic resistance.

11 Apr 2026

New Experimental System Mimics Low-Grade Pediatric Glioma in 3D

A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children.

10 Apr 2026

Non-Coding DNA Mutations Identified as Cause of Rare Neonatal Diabetes

Scientists have found new genetic causes for diabetes in babies – in a part of the genome that has historically been overlooked in genetic studies.

10 Apr 2026

Study Reveals How Bacteria Protect Themselves During Cell Cleavage

Bacteria reproduce by dividing into two: they form a wall, or septum, between the two future cells while remodeling the old cell walls so the so-called "daughter" cells can separate without bursting.

10 Apr 2026

CIPHER-seq Reveals RNA and Protein Activity in Immune Cells

A new single-cell technology is giving scientists their clearest view yet of immune cell behavior-capturing not just genetic intent but real-time activity.

9 Apr 2026

How Cancer Cells Evade Chemotherapy-Induced Apoptosis

Researchers at Umeå University have provided new insights into how cancer cells defend themselves against cell death.

8 Apr 2026

New Mouse Model Reveals Viral Path to Liver Cancer

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease unfolds in people, from initial infection with a virus to liver inflammation, scarring, and cancer.

7 Apr 2026

Novel ENDOtollins Block Harmful Inflammation While Preserving Infection Response

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the body's ability to fight infections intact-a long-sought goal in treating autoimmune diseases.

7 Apr 2026

MPGK Tool Streamlines Advanced Genetic Data Analysis for Bioinformatics Beginners

With the rapid expansion of genome-wide association studies (GWAS), researchers are increasingly faced with the challenge of translating large-scale genetic data into meaningful biological insights.

6 Apr 2026

Experimental Flu Vaccine That Protects Against Multiple Strains in Mice

According to a study published by investigators at Georgia State University’s Institute for Biomedical Sciences, a novel vaccine platform has been created to generate broad, protective immunity against multiple influenza virus infections, demonstrating potential as an effective mucosal vaccination approach.

6 Apr 2026

Tumors Disable Dendritic Cells by Decreasing Mitochondrial Fitness

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer - and how restoring their energy production can improve immunotherapy.

3 Apr 2026

Defining Tumor Microbiota for Improved Cancer Diagnosis and Treatment

Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the effectiveness of therapies, highlighting the need to standardize methods for studying intratumoral microbes.

3 Apr 2026

Cysteine Pathways Shape T Cell Expansion and Cancer Defense

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health have discovered how the immune system's CD8+ T cells use the nutrient cysteine to control two essential functions that compete for this resource - the immune cell's ability to multiply and its ability to kill cancer cells.

1 Apr 2026

Antibiotic Degrading Bacteria Enhance Microbial Stability and Ecosystem Resilience

By comparing natural microbial adaptation with targeted bioaugmentation using an antibiotic-degrading strain, the study reveals how biodegradation capacity fundamentally reshapes microbial succession, stability, and resilience under sustained antibiotic exposure.

1 Apr 2026

Nonviral Nanoparticles Show Promise for Safer Gene Delivery Methods

In a demonstration that helps pave the way for gene therapies with fewer side effects, several human cell types were genetically modified with protein nanoparticles designed at University of Michigan Engineering and Michigan Medicine.

1 Apr 2026

How To Create Long-Lasting Immune Cells For Stronger Vaccines

Scientists at the University of Wisconsin School of Veterinary Medicine have identified a potential approach to develop longer-lasting vaccines for respiratory viruses such as influenza and the coronavirus that causes COVID-19.

1 Apr 2026

Discovery Challenges the Theory That Proteins Move Mainly by Diffusion

Scientists at Oregon Health & Science University have uncovered a previously unknown system of internal "trade winds" that help cells rapidly move essential proteins to the front of the cell, reshaping how researchers understand cell migration, cancer spread and wound healing.

31 Mar 2026

Study Reveals How Trypanosomes Fine-Tune Protein Production Through Destruction

To survive in the human bloodstream, the African trypanosome parasite wears a "cloak" made of proteins known as a variant surface glycoprotein (VSG). The study, published in Nature Microbiology, identifies the protein that allows the parasite to fine-tune this "cloak".

31 Mar 2026